Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results
Embecta Corp. (EMBC)
Company Research
Source: GlobeNewswire
PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month period ended December 31, 2023. "Building on our performance during 2023, embecta delivered strong results for the first quarter of 2024," said Devdatt (Dev) Kurdikar, Chief Executive Officer of embecta. "During the first quarter, I am pleased to report that we transitioned approximately sixty percent of our revenue to our own ERP system, shared service capability and distribution infrastructure, while delivering financial results that exceeded our expectations. Importantly, we also made progress on our strategic priorities, including the 510(k) filing of our open-loop patch pump with the FDA. Given our performance during the first quarter, coupled with our outlook for the remainder of the year, we are raising our guidance for certain key financial reporting metrics." First Quarter Fiscal
Show less
Read more
Impact Snapshot
Event Time:
EMBC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EMBC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EMBC alerts
High impacting Embecta Corp. news events
Weekly update
A roundup of the hottest topics
EMBC
News
- Pleasing Signs As A Number Of Insiders Buy Embecta Stock [Yahoo! Finance]Yahoo! Finance
- embecta to Participate in Investor EventsGlobeNewswire
- embecta to Report Fiscal Second Quarter 2024 Financial ResultsGlobeNewswire
- embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 DiabetesGlobeNewswire
- Europe Pen Needles Market Forecast Report to 2030, Featuring Embecta, Novo Nordisk, Ypsomed, B.Braun Melsungen, Terumo, Nipro, Owen Mumford, Arkray, UltiMed and Allison Medical [Yahoo! Finance]Yahoo! Finance
EMBC
Earnings
- 2/9/24 - Beat
EMBC
Sec Filings
- 4/23/24 - Form 3/A
- 4/23/24 - Form 3/A
- 4/8/24 - Form 4
- EMBC's page on the SEC website